课题基金 / 基金详情

Detection of lung adenocareinoma cells in peripheral blood by RT-PCR analysis for mRNA of surfactant protein

Detection of lung adenocareinoma cells in peripheral blood by RT-PCR analysis for mRNA of surfactant protein
RT-PCR检测外周血肺腺癌细胞表面活性蛋白mRNA
批准号:
12670567
负责人:
ABE Shosaku
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

ABE Shosaku的其他基金

相似基金

相关文献

中文摘要
翻译
肺癌分期患者的5年生存率。1只有60-70%。肺癌的预后通常因乳房扩散而受损。为了检测外周血循环肺癌eelIs,我们对SP-A、SP-C和CC10的mRNA进行了RT-PCR分析。19例健康志愿者SP-A、SP-C、CC10 mrna表达均为阴性。99例非小细胞肺癌患者中有33例(33.3%)检测到SP-A mRNA。SP-CmRNA阳性率(14%)和CC10mRNA阳性率(8%)较低。SP-A mRNA在1期患者中的阳性表达率为26%,SPA mRNA的阳性率明显高于SP-C mRNA(8%)和CC-10mRNA(3%)。所有病例经根治性手术后SP-A mRNA阳性表达消失。RT-PCR检测SP-A mRNA对检测外周血中隐匿性转移性肺腺癌细胞有临床意义。
英文摘要
The 5 years survival of lung cancer patients with stage.1 is only 60-70%. The prognosis of lung cancer is usually impaired with melastalic dissemination. To detect circulating lung cancer eelIs in peripheral blood, we performed RT-PCR analysis for mRNA of SP-A, SP-C and CC10.The 19 samples from healthy volunteers were all negative for SP-A, SP-C, CC10 mRNA.expression. SP-A mRNA was detected in 33 patients (33.3%) with 99 nonsmall cell lung cancer. The positive rale of SP-CmRNA(14 %) and CC10mRNA(8 %) were low. The positivity of expression for SP-A mRNA in the patients with stage 1 was 26 %, and the positive rate of SPA mRNA was higher than SP-C mRNA (8 %) and CC-10mRNA(3 %) significantly. The positive samples of SP-A mRNA expression disappeared with all cases after a curative surgical operation.RT-PCR analysis for SP-A mRNA is clinically useful for the detection occult metastatic lung adenocarcinoma cells in periferal blood.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
黒木由夫 他: "肺サーファクタント"SRL宝函. 23. 228-233 (2000)
Yoshio Kuroki 等人:“肺表面活性物质”SRL Takarabako。23. 228-233 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Thkahashi H, et al.: "Serum surfactatnt proteins A and D as prognostic factors in idiopathic pulmonary fibrosi and their relationship to disease extent"AmJ Respir Crit Care Med.. 162(3). 1109-1114 (2000)
Thrkahashi H 等人:“血清表面活性蛋白 A 和 D 作为特发性肺纤维化的预后因素及其与疾病程度的关系”AmJ Respir Crit Care Med. 162(3)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Murakami M, et al.: "The mechanisms by which surfactant protein A and D appear in the bloodstream and the intra-alveolar space are different between idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis."Airway Secetion Res. 2. 57-64 (2000)
Murakami M 等人:“特发性肺纤维化和肺泡蛋白沉积症之间,表面活性蛋白 A 和 D 出现在血流和肺泡内的机制是不同的。”气道部分研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takahashi H, et al.: "Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosi and their relationship to disease extent."Am J Respir Crit Care Med.. 162(3). 1109-1114 (2000)
Takahashi H 等人:“血清表面活性蛋白 A 和 D 作为特发性肺纤维化的预后因素及其与疾病程度的关系。”Am J Respir Crit Care Med. 162(3)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
19
    Cell-Molecular Biological Study on Detectin of Occult Metastatic Lesions in Lung Cancer
    • 批准号:
      07457148
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $1.98万
    • 财政年份:
      1995
    • 负责人:
      ABE Shosaku
    • 依托单位:
    RFLP analysis of HLA and T cell receptor genes in sarcoidosis
    • 批准号:
      01570418
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.22万
    • 财政年份:
      1989
    • 负责人:
      ABE Shosaku
    • 依托单位:
    国内基金
    海外基金
    PLAGL2对SP-C基因表达调控的研究
    • 批准号:
      30971072
    • 项目类别:
      面上项目
    • 资助金额:
      31.0万元
    • 批准年份:
      2009
    • 负责人:
      邓飞涛
    • 依托单位:
    肺表面蛋白SP-C在肺泡单分子膜内的空间构象和生理机制研究
    • 批准号:
      20876047
    • 项目类别:
      面上项目
    • 资助金额:
      27.0万元
    • 批准年份:
      2008
    • 负责人:
      曾作祥
    • 依托单位: